Adjuvant radiotherapy (RT) and trastuzumab in stage I-IIA breast cancer: Toxicity data from North Central Cancer Treatment Group Phase III trial N9831

Reviewer: Christopher Dolinsky, MD
University of Pennsylvania School of Medicine
Ultima Vez Modificado: 5 de junio del 2006

Translation for this article does not exist

Blogs

Cancer and Hair Loss
by Bob Riter
February 11, 2016